verified SJR 2,449 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed

Italy · Ferrata Storti Foundation

workspace_premium Q1 — Hematology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Haematologica

Haematologica is a journal indexed in SJR in Hematology with an H index of 172. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 1600 €. The scope of the journal is focused on hematology, oncology. It has an SJR impact factor of 2,449 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,449.

Haematologica focuses its scope in these topics and keywords: cell, disease, lymphoma, gene, myeloma, myeloid, multiple, leukemia, inhibits, survival, ...

ISSN: 0390-6078

Publisher: Ferrata Storti Foundation

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

2,449 Q1

H-index 172

Acceptance rate pie_chart

22% Selective

Source Acceptance_Rate

Time to publication hourglass_top

8 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

1.600 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

2,449

H-index

172

Docs (year)

545

Docs 3y

1247

Total refs

14446

Cites 3y

5217

Citable 3y

721

Cites/Doc 2y

3.99

Ref/Doc

26.51

Immediate OA

1600 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography

Usefulness of initial plasma dabigatran concentration to predict rebound after reversal

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis

Constitutional

Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: a retrospective study from a hematology tertiary care center

Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway

Complement deposition in autoimmune hemolytic anemia is a footprint for difficult-to-detect IgM autoantibodies

Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review

Co-expression of the collagen receptors leukocyte-associated immunoglobulin-like receptor-1 and glycoprotein VI on a subset of megakaryoblasts

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients

Clinical and pathogenic features of

Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes

SHOW MORE ARTICLES

Chimeric antigen receptor T-cell therapy for acute myeloid leukemia: how close to reality?

"Comment on ""Acute lymphoblastic leukemia and adiponcosis"" by M. Bifulco and AM Malfitano"

Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol

Bone marrow histomorphological criteria can accurately diagnose hemophagocytic lymphohistiocytosis

Association of transforming growth factor- 1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases

Antigen receptor sequencing of paired bone marrow samples shows homogeneous distribution of acute lymphoblastic leukemia subclones

Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia

Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood

Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of

Acute myeloid leukemia with expanded erythropoiesis

A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes: expression of CD56 in CMML

A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients

FAQs

Haematologica has an SJR of 2,449 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 1600 EUR.

The acceptance rate recorded for Haematologica is 22%.

Haematologica

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Haematologica?

What is the APC / publication cost?

What is the acceptance rate?